查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1378937

2023-2028 年按产品、应用、最终用途和地区分類的病毒过滤市场报告

Virus Filtration Market Report by Product, Application, End Use, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球病毒过滤市场规模达39亿美元。展望未来， IMARC Group预计到2028年市场规模将达到69亿美元，2022-2028年复合年增长率（CAGR）为10.0%。全球健康危机的发生率不断上升，在紧张的工期内大规模生产生物製药的需求不断增长，以及对新药、疗法和疫苗开发的投资不断增加，是推动市场成长的关键因素。

病毒过滤是生物製药生产过程中的关键步骤，旨在确保疫苗、抗体和生物製剂等医药产品的安全性和纯度。此方法用于去除可能对人类健康有害的病毒污染物。它对于直接进入体内的肠外药物的生产尤其重要，因此需要高纯度标准。通常，使用具有特定孔径的专用薄膜过滤器来捕获和去除病毒。这些过滤器旨在允许所需产品通过，同时有效捕捉病毒颗粒。该流程在实施前经过严格验证，并定期进行测试以确认其有效性。此外，它还可以作为药品生产的强大保障，提高产品安全性和符合法规要求。

全球市场主要受到流行病和广泛病毒爆发等全球健康危机不断升级的推动。这凸显了这种过滤技术对于确保医疗用品和药品安全的重要性。在此期间，对疫苗和其他治疗剂的需求呈指数级增长。这项需求使得生物製药必须在紧迫的时间内进行大规模生产，同时又不影响安全性。因此，这对市场有正面影响。除此之外，生物製药产业合约製造组织（CMO）的兴起是促进市场成长的另一个重要因素。此外，对新药物、疗法和疫苗开发的投资不断增加，这些投资本质上需要这些流程来确保安全性和合规性，这也极大地支持了市场。

病毒过滤市场趋势/驱动因素：

对生物製药的需求不断增加

病毒过滤产业的重要市场驱动力之一是对单株抗体、重组蛋白和疫苗等生物製药的需求不断增长。这些复杂的分子通常源自活细胞，使它们容易受到病毒污染。同时，癌症、糖尿病和自体免疫疾病等慢性疾病盛行率的上升正在影响市场。需求的成长给製造商带来了生产符合严格安全和品质标准的生物製药的负担。在这种情况下，病毒过滤成为不可或缺的步骤，因为它对于确保这些产品的纯度和安全性至关重要。监管机构正在製定严格的病毒清除指南，进一步强调了这些技术的重要性。随着越来越多的生物製药进入市场或进行临床试验，对病毒过滤服务的需求也随之加速，从而推动产业向前发展。

技术和研究的不断进步

过滤膜和方法领域的技术进步正在显着影响病毒过滤产业的成长。同时，更有效率、可扩展且更具成本效益的过滤系统的开发使製药公司更容易将这些解决方案整合到其现有的生产线中。奈米技术和材料科学的创新使过滤器具有更高的效率和更好的吞吐能力，从而能够更快速、更可靠地去除病毒。随着过滤技术的研究和开发工作不断进行，该领域的公司正在增加该技术的采用。这项技术进步提高了药品製造的水平，并为全球市场提供了强大的市场驱动力。

更加重视法规遵从性和品质保证

遵守监管标准是病毒过滤产业的要求和市场驱动力。各机构对生物源医药产品的病毒安全性有具体的指导方针。这些指南通常需要采取多个步骤来清除病毒，包括病毒过滤。满足这些监管期望对于製药公司获得产品批准和维持市场信誉至关重要。考虑到病毒污染带来的可怕后果，从产品上市延迟到法律责任，对监管合规性的重视成为采用病毒过滤技术的强制力量。此外，该行业受益于对品质保证的高度关注，使其成为生物製药製造价值链的重要组成部分。

病毒过滤产业区隔：

IMARC Group提供了全球病毒过滤市场报告各细分市场主要趋势的分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据产品、应用和最终用途对市场进行了分类。

按产品划分：

耗材

试剂盒和试剂

其他的

仪器

过滤系统

色谱系统

服务

耗材占据最大市场份额

该报告根据产品提供了详细的市场细分和分析。这包括消耗品（试剂盒和试剂等）、仪器（过滤系统、色谱系统）和服务。报告显示，消耗品占据了最大的市场份额。

由于製药过程中对过滤耗材（例如膜、滤芯和盒）的反覆需求，病毒过滤行业的耗材市场正在经历大幅增长。与生命週期长的资本设备不同，消耗品在单一製造週期中使用，需要频繁更换，以确保需求的一致性。此外，越来越多地采用一次性技术，特别是在生物加工领域，增加了对一次性过滤耗材的需求，这些耗材被认为更方便且不易发生交叉污染。此外，监管机构不断收紧生物製药产品病毒安全指南，这反过来又需要使用符合这些严格标准的高品质消耗品。此外，疫苗和疗法的不断开发和製造，特别是在包括流行病在内的全球健康危机期间，大大增加了这些一次性产品的消费。

按应用划分：

生物製品

疫苗和治疗方法

血液和血液製品

细胞和基因疗法产品

其他的

医疗设备

净水

空气净化

其他的

生物製品占据大部分市场份额

报告还提供了基于应用程式的详细市场细分和分析。这包括生物製品（疫苗和治疗药物、血液和血液製品、细胞和基因治疗产品等）、医疗器材、水净化、空气净化等。报告称，生物製品占据最大的市场份额。

生物製品领域是推动市场的关键应用领域，这主要是由于对单株抗体、疫苗和基因疗法等生物疗法产品的需求不断增长。这些复杂的分子是在活细胞中产生的，使它们容易受到病毒污染，因此需要强大的过滤过程。同时，对生物製品安全性的监管审查也在加强，各机构要求采取严格的病毒清除措施。这些监管要求强制执行严格的品质控制，推动先进的病毒过滤技术在生物领域的采用。此外，癌症、糖尿病和自体免疫疾病等慢性疾病的盛行率不断上升，也增加了对生物治疗的需求。此外，製药公司正在提高生产能力并实施最先进的过滤方法，以满足消费者需求和监管要求。

按最终用途细分：

生物製药和生物技术公司

合约研究组织

学术机构与研究实验室

其他的

生物製药和生物技术公司占据最大的市场份额

该报告根据最终用途提供了详细的市场细分和分析。这包括生物製药和生物技术公司、合约研究组织、学术机构和研究实验室等。报告显示，生物製药和生技公司占据了最大的市场。

对生物製药的需求不断增长和生物技术公司的快速成长是病毒过滤行业的关键市场驱动力。这些实体处于开发复杂生物产品（如单株抗体、疫苗和重组蛋白）的最前沿，这些产品本质上容易受到病毒污染。此外，确保产品安全性和有效性的必要条件是科学必要性和监管要求。同时，组织正在製定严格的指导方针，要求应用强大的病毒过滤流程来确保品质。随着生物製药在治疗从慢性病到疫情相关疾病等一系列疾病中变得越来越重要，对有效病毒过滤的需求也随之成长。此外，CRISPR和基因疗法等生物技术的进步进一步扩大了生物产品的范围和复杂性，从而增强了对先进病毒过滤解决方案的必要性。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的病毒过滤市场份额

市场研究报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美地区占最大份额。

在有利的产业扩张环境的推动下，北美市场正在经历显着成长。主要驱动因素之一是全球生物製药公司和先进研究机构在该地区的强劲存在，这需要高品质的病毒过滤解决方案来确保产品安全。同时，各机构制定的监管框架正在执行严格的病毒清除指南，从而提高了对高效过滤技术的需求。此外，北美一直是生物技术进步的先驱，为新疗法、疫苗和其他需要病毒过滤的生物产品的开发做出了贡献。

除此之外，该地区医疗保健研发投资的大幅成长，进一步推动了市场的成长。全球健康危机（例如流行病）的发生通常会导致疫苗和治疗药物生产迅速扩大，从而大大增加对可靠病毒过滤系统的需求。所有这些因素汇聚在一起，使北美成为病毒过滤技术的强大市场，推动了该行业的创新和采用。

竞争格局：

主要参与者不断致力于开发更有效率、更可靠的过滤技术。这包括过滤膜、过滤系统和一次性技术的创新，以便为客户提供更好的解决方案。除此之外，各大公司都提供满足或超过这些法规的产品和服务，通常为其客户提供强大的验证支援。此外，公司正在建立策略合作伙伴关係或收购，以扩大其地理范围和产品组合。除此之外，有些品牌在其产品的同时也提供咨询服务，以帮助客户优化其过滤流程，这是另一个促进成长的因素。随着人们对环境责任的日益关注，一些公司正在探索和开发更永续的过滤技术，例如可重复使用或可回收的过滤组件。

市场研究报告对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

旭化成医疗株式会社

查尔斯河实验室公司

清洁细胞

丹纳赫公司

默克公司

赛多利斯公司

赛默飞世尔科技公司

最近的发展：

2023 年 3 月，Charles River Laboratories Inc. 宣布发布其现成的 pHelper 解决方案，该解决方案旨在加快并确保基于 AAV 的基因治疗项目从研究早期阶段到商业生产的供应。

2022年2月，旭化成医疗株式会社宣布在日本宫崎延冈市新建组装工厂，以提高PlanovaTM过滤器的产能。

2021 年 9 月，Clean Cells 宣布投资 1,300 万欧元（1,530 万美元）投资新建 Montaigu-Vendee 製造厂。该组织由医疗保健投资公司 ArchiMed 支持，希望透过将生物製药的分析和生产能力提高四倍，在加快 COVID-19 创新药物和疫苗的开发和上市时间方面发挥重要作用。

本报告回答的关键问题

  • 2022年全球病毒过滤市场规模有多大
  • 2023-2028年全球病毒过滤市场的预期成长率是多少
  • 推动全球病毒过滤市场的关键因素是什么
  • COVID-19 对全球病毒过滤市场有何影响
  • 基于产品的全球病毒过滤市场的细分是什么
  • 基于应用的全球病毒过滤市场的细分是什么
  • 根据最终用途，全球病毒过滤市场的细分如何
  • 全球病毒过滤市场的重点区域有哪些
  • 谁是全球病毒过滤市场的主要参与者/公司

本报告回答的关键问题

  • 2022年全球病毒过滤市场规模有多大？
  • 2023-2028年全球病毒过滤市场的预期成长率是多少？
  • 推动全球病毒过滤市场的关键因素是什么？
  • COVID-19 对全球病毒过滤市场有何影响？
  • 基于产品的全球病毒过滤市场的细分情况如何？
  • 基于应用的全球病毒过滤市场的细分情况如何？
  • 根据最终用途，全球病毒过滤市场的细分情况如何？
  • 全球病毒过滤市场的关键区域有哪些？
  • 全球病毒过滤市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球病毒过滤市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 耗材
    • 市场走向
    • 主要类型
      • 试剂盒和试剂
      • 其他的
    • 市场预测
  • 仪器
    • 市场走向
    • 主要类型
      • 过滤系统
      • 色谱系统
    • 市场预测
  • 服务
    • 市场走向
    • 市场预测

第 7 章：按应用分類的市场区隔

  • 生物製品
    • 市场走向
    • 主要类型
      • 疫苗和治疗方法
      • 血液和血液製品
      • 细胞和基因疗法产品
      • 其他的
    • 市场预测
  • 医疗设备
    • 市场走向
    • 市场预测
  • 净水
    • 市场走向
    • 市场预测
  • 空气净化
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：依最终用途分類的市场区隔

  • 生物製药和生物技术公司
    • 市场走向
    • 市场预测
  • 合约研究组织
    • 市场走向
    • 市场预测
  • 学术机构与研究实验室
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Asahi Kasei Medical Co. Ltd.
    • Charles River Laboratories Inc.
    • Clean Cells
    • Danaher Corporation
    • Merck KGaA
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A3423

Abstract

The global virus filtration market size reached US$ 3.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2028, exhibiting a growth rate (CAGR) of 10.0% during 2022-2028. The rising occurrences of global health crises, the growing need for mass production of biopharmaceuticals under tight schedules, and the growing investments in the development of new medicines, therapies, and vaccines are among the key factors driving the market growth.

Virus filtration is a critical step in the biopharmaceutical manufacturing process aimed at ensuring the safety and purity of medicinal products, including vaccines, antibodies, and biologics. This method is employed to remove viral contaminants that could be harmful to human health. It is especially essential in the production of parenteral medications, which are introduced directly into the body and thus require high purity standards. Typically, specialized membrane filters with defined pore sizes are used to capture and remove viruses. These filters are designed to allow the passage of the desired product while effectively trapping viral particles. The process is rigorously validated before implementation, and periodic testing is performed to confirm its effectiveness. Furthermore, it serves as a robust safeguard in pharmaceutical manufacturing, enhancing product safety and compliance with regulatory requirements.

The global market is majorly driven by the escalating occurrence of global health crises such as pandemics and widespread viral outbreaks. This highlights the importance of this filtration technique to ensure the safety of medical supplies and pharmaceuticals. During such times, there is an exponential increase in the demand for vaccines and other therapeutic agents. This demand necessitates the mass production of biopharmaceuticals under tight schedules, without compromising on safety. Therefore, this is positively influencing the market. Along with this, the rise of contract manufacturing organizations (CMOs) in the biopharmaceutical industry is another significant factor contributing to the growth of the market. In addition, the escalating investments in the development of new medicines, therapies, and vaccines, which inherently require these processes for safety and compliance are also significantly supporting the market.

Virus Filtration Market Trends/Drivers:

Increasing demand for biopharmaceuticals

One of the significant market drivers for the virus filtration industry is the growing demand for biopharmaceuticals such as monoclonal antibodies, recombinant proteins, and vaccines. These complex molecules are often derived from living cells, making them susceptible to viral contamination. Along with this, the rising prevalence of chronic diseases, including cancer, diabetes, and autoimmune disorders is impacting the market. This increase in demand places a burden on manufacturers to produce biopharmaceuticals that meet stringent safety and quality criteria. Virus filtration becomes an indispensable step in this scenario, as it is crucial for ensuring the purity and safety of these products. Regulatory bodies are imposing strict guidelines for viral clearance, further emphasizing the importance of these technologies. As more biopharmaceuticals enter the market or undergo clinical trials, the need for virus filtration services is accelerating correspondingly, thereby driving the industry forward.

Continual advancements in technology and research

Technological advancements in the field of filtration membranes and methods are significantly impacting the growth of the virus filtration industry. Along with this, the development of more efficient, scalable, and cost-effective filtration systems is making it easier for pharmaceutical companies to integrate these solutions into their existing production lines. Innovations in nanotechnology and material science are leading to filters with higher efficacy and better throughput capabilities, thus enabling more rapid and reliable virus removal. As research and development efforts continue in filtration technology, companies operating in this domain are increasing the adoption of the technology. This technological progress elevates the standard of pharmaceutical manufacturing and serves as a strong market driver for the global market.

An enhanced focus on regulatory compliance and quality assurance

Compliance with regulatory standards is a requirement and a market driver for the virus filtration industry. Agencies have specific guidelines about the viral safety of biologically-derived medicinal products. These guidelines often necessitate multiple steps for viral clearance, including virus filtration. Meeting these regulatory expectations is paramount for pharmaceutical companies to obtain product approvals and maintain market credibility. Given the dire consequences of viral contamination, ranging from delayed product launches to legal liabilities, the emphasis on regulatory compliance acts as a compelling force for the adoption of virus filtration technologies. Moreover, the industry benefits from this heightened focus on quality assurance, making it an essential component in the biopharmaceutical manufacturing value chain.

Virus Filtration Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global virus filtration market report, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product, application, and end use.

Breakup by Product:

Consumables

Kits and Reagents

Others

Instruments

Filtration Systems

Chromatography Systems

Services

Consumables hold the largest market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables (kits and reagents, and others), instruments (filtration systems, chromatography systems), and services. According to the report, consumables accounted for the largest market share.

The market for consumables in the virus filtration industry is experiencing substantial growth, driven by the recurring need for filtration consumables, such as membranes, cartridges, and cassettes in the pharmaceutical manufacturing process. Unlike capital equipment that has a long lifecycle, consumables are used in a single manufacturing cycle and need frequent replacement, ensuring a consistent demand. Furthermore, the increasing adoption of single-use technologies, particularly in bioprocessing, amplifies the need for disposable filtration consumables, which are viewed as more convenient and less prone to cross-contamination. In addition, regulatory bodies are continually tightening the guidelines for viral safety in biopharmaceutical products, which, in turn, necessitates the use of high-quality consumables that meet these stringent standards. Moreover, the growing development and manufacturing of vaccines and therapies, especially during global health crises, including pandemics, drastically increase the consumption of these disposable products.

Breakup by Application:

Biologicals

Vaccines and Therapeutics

Blood and Blood Products

Cellular and Gene Therapy Products

Others

Medical Devices

Water Purification

Air Purification

Others

Biologicals account for the majority of the market share

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes biologicals (vaccines and therapeutics, blood and blood products, cellular and gene therapy products, and others), medical devices, water purification, air purification, and others. According to the report, biologicals accounted for the largest market share.

The biologicals segment is a key application area driving the market, primarily due to the rising demand for biotherapeutic products, such as monoclonal antibodies, vaccines, and gene therapies. These complex molecules are produced in living cells, making them vulnerable to viral contamination, thereby necessitating robust filtration processes. Along with this, regulatory scrutiny over the safety of biological products is intensifying, with agencies mandating rigorous viral clearance steps. These regulatory imperatives enforce stringent quality controls, propelling the adoption of advanced virus filtration technologies in the biologicals domain. In addition, the increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune conditions has also amplified the need for biotherapeutic treatments. Moreover, pharmaceutical companies are ramping up their production capacities and implementing state-of-the-art filtration methods to meet both consumer demand and regulatory requirements.

Breakup by End Use:

Biopharmaceuticals and Biotechnology Companies

Contract Research Organizations

Academic Institutes and Research Laboratories

Others

Biopharmaceuticals and biotechnology companies hold the largest market share

The report has provided a detailed breakup and analysis of the market based on the end use. This includes biopharmaceuticals and biotechnology companies, contract research organizations, academic institutes and research laboratories, and others. According to the report, biopharmaceuticals and biotechnology companies accounted for the largest market share.

The escalating demand for biopharmaceuticals and the rapid growth of biotechnology companies serve as pivotal market drivers in the virus filtration industry. These entities are at the forefront of developing complex biological products such as monoclonal antibodies, vaccines, and recombinant proteins, which are inherently susceptible to viral contamination. Additionally, the imperative for ensuring product safety and efficacy is a scientific necessity and a regulatory mandate. In confluence with this, organizations are setting stringent guidelines that require the application of robust virus filtration processes for quality assurance. As biopharmaceuticals become increasingly central in treating a range of diseases, from chronic conditions to pandemic-related illnesses, the need for effective virus filtration grows proportionally. Furthermore, advancements in biotechnology, such as CRISPR and gene therapy, have further extended the scope and complexity of bioproducts, subsequently amplifying the necessity for advanced virus filtration solutions.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest virus filtration market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest segment.

The market in North America is experiencing significant growth, propelled by a favorable environment for industry expansion. One of the leading drivers is the robust presence of global biopharmaceutical companies and advanced research institutions in the region, which necessitates high-quality virus filtration solutions for product safety. Along with this, regulatory frameworks set by agencies are enforcing stringent guidelines on viral clearance, thereby elevating the demand for efficient filtration technologies. In addition, North America has been a pioneer in biotechnological advancements, contributing to the development of new therapies, vaccines, and other bioproducts that require virus filtration.

Besides this, considerable growth in the investment in healthcare research and development is substantial in this region, further fueling the growth of the market. The occurrence of global health crises, such as pandemics, often leads to a rapid scale-up in vaccine and therapeutic production, dramatically increasing the need for reliable virus filtration systems. All these elements converge to make North America a strong market for virus filtration technologies, driving both innovation and adoption in the industry.

Competitive Landscape:

The key players are continually working on developing more efficient and reliable filtration technologies. This includes innovations in filter membranes, filtration systems, and single-use technologies to provide better solutions to clients. Along with this, the major companies are offering products and services that meet or exceed these regulations, often providing robust validation support for their customers. In addition, companies are entering into strategic partnerships or acquisitions to expand their geographical reach and product portfolio. Apart from this, several brands are offering consultancy services alongside their products to help customers optimize their filtration processes, which is acting as another growth-inducing factor. With an increasing focus on environmental responsibility, some companies are exploring and developing more sustainable filtration technologies, such as reusable or recyclable filter components.

The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Asahi Kasei Medical Co. Ltd.

Charles River Laboratories Inc.

Clean Cells

Danaher Corporation

Merck KGaA

Sartorius AG

Thermo Fisher Scientific Inc.

Recent Developments:

In March 2023, Charles River Laboratories Inc. announced the release of its off-the-shelf pHelper solution, which is intended to expedite and assure supplies for AAV-based gene therapy programs from the early stages of research to commercial manufacture.

In February 2022, Asahi Kasei Medical Co. Ltd. announced to build of a new assembly factory in Nobeoka, Miyazaki, Japan in order to increase the production capacity of PlanovaTM filters.

In September 2021, Clean Cells announced a €13 million ($15.3 million) investment in a new Montaigu-Vendee manufacturing facility. The organization supported by healthcare investment firm ArchiMed wants to play a significant part in accelerating the development and time-to-market of innovative medicines and vaccines for COVID-19 by quadrupling its analytical and production capacity for biopharmaceuticals.

Key Questions Answered in This Report

  • 1. What was the size of the global virus filtration market in 2022?
  • 2. What is the expected growth rate of the global virus filtration market during 2023-2028?
  • 3. What are the key factors driving the global virus filtration market?
  • 4. What has been the impact of COVID-19 on the global virus filtration market?
  • 5. What is the breakup of the global virus filtration market based on the product?
  • 6. What is the breakup of the global virus filtration market based on the application?
  • 7. What is the breakup of the global virus filtration market based on the end use?
  • 8. What are the key regions in the global virus filtration market?
  • 9. Who are the key players/companies in the global virus filtration market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Virus Filtration Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Kits and Reagents
      • 6.1.2.2 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Filtration Systems
      • 6.2.2.2 Chromatography Systems
    • 6.2.3 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Biologicals
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Vaccines and Therapeutics
      • 7.1.2.2 Blood and Blood Products
      • 7.1.2.3 Cellular and Gene Therapy Products
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Medical Devices
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Water Purification
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Air Purification
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Biopharmaceuticals and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic Institutes and Research Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Asahi Kasei Medical Co. Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Charles River Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Clean Cells
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Merck KGaA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sartorius AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Thermo Fisher Scientific Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Virus Filtration Market: Major Drivers and Challenges
  • Figure 2: Global: Virus Filtration Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Virus Filtration Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Virus Filtration Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Virus Filtration Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Virus Filtration Market: Breakup by End Use (in %), 2022
  • Figure 7: Global: Virus Filtration Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Virus Filtration (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Virus Filtration (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Virus Filtration (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Virus Filtration (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Virus Filtration (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Virus Filtration (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Virus Filtration (Biologicals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Virus Filtration (Biologicals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Virus Filtration (Medical Devices) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Virus Filtration (Medical Devices) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Virus Filtration (Water Purification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Virus Filtration (Water Purification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Virus Filtration (Air Purification) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Virus Filtration (Air Purification) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Virus Filtration (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Virus Filtration (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Virus Filtration (Biopharmaceuticals and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Virus Filtration (Biopharmaceuticals and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Virus Filtration (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Virus Filtration (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Virus Filtration (Academic Institutes and Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Virus Filtration (Academic Institutes and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Virus Filtration (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Virus Filtration (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia-Pacific: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia-Pacific: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Virus Filtration Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Virus Filtration Market: Breakup by Country (in %), 2022
  • Figure 80: Middle East and Africa: Virus Filtration Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Global: Virus Filtration Industry: SWOT Analysis
  • Figure 82: Global: Virus Filtration Industry: Value Chain Analysis
  • Figure 83: Global: Virus Filtration Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Virus Filtration Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Virus Filtration Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Virus Filtration Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Virus Filtration Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Virus Filtration Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Virus Filtration Market: Competitive Structure
  • Table 7: Global: Virus Filtration Market: Key Players